LIDDS: Licensavtal med kinesisk partner

Research Note

2018-05-16

15:27

LIDDS har skrivit ett licensieringsavtal rörande Liproca Depot med det kinesiska farmabolaget Jiangsu Ambition Medical.

MS

Mathias Spinnars

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.